For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…
DelveInsight's Drug-Eluting Stents - Market Insights, Competitive Landscape and Market Forecast-2026' report delivers an in-depth understanding of Drug-Eluting Stents and the historical and forecasted Drug-Eluting Stents market trends in the US, EU5 (Germany, France, Spain, Italy, and the United Kingdom) and Japan.
The Drug-Eluting Stents market report provides an overview of Drug-Eluting Stents, applications of Drug-Eluting Stents as well as its PEST Analysis. Additionally, the report provides insight on the Drug-Eluting Stents market share of the individual Drug-Eluting Stents, current and forecasted Drug-Eluting Stents market size from 2018 to 2026 segmented by seven major markets. The report also covers the market drivers, market barriers and unmet medical needs to curate best of the opportunities and assesses underlying potential of the market.
Drug-Eluting Stents Overview
Stents are small, expandable tubes inserted after percutaneous coronary intervention (PCI) to keep the arteries open and improve the blood flow. In general, stents are classified into two: bare metal stents and drug eluting stents. Earlier the drug eluting stents were made of stainless steel and were coarse. Currently, new generation drug eluting stents are in more use as they are made of different kinds of alloys, such as cobalt chromium or platinum chromium, are thinner, have high radial strength and radiopacity, and enhance biocompatibility as well as corrosion resistance.
Study Period: 2018-2026
Geography Covered
- The US
- EU5 (Germany, France, Spain, Italy, and the United Kingdom)
- Japan
List of Companies
Abbott, Braun Melsungen AG, Biosensors International Group, Ltd, BIOTRONIK SE & Co. KG, Boston Scientific Corporation, Terumo Corporation, Medtronic, MicroPort Scientific Corporation, STENTYS SA, Lepu Medical, Cook, and Cardinal Health, among others
Drug-Eluting Stents - Competitive Analysis
This segment of the report provides a brief competitive analysis of Drug-Eluting Stents, to help understand the competition in the market. It gives a comparative understanding of the products based on type.
Drug-Eluting Stents: Market Segmentation
By Product Type
- Coronary stent
- Peripheral stent
By Scaffold
- Cobalt-chromium alloy
- Nitinol
- Others
By End-User
- Hospitals
- Specialty Clinics
Drug-Eluting Stents: Market Dynamics
Market Drivers
- Rising demand for minimally invasive procedures
- Shifting preferences towards drug-eluting stents over angioplasty
Market Barriers
- Risk associated with the stents
Drug-Eluting Stents: Market Analysis
This segment illustrates the market of Drug-Eluting Stents across the 7MM and how the market is expected to rise in the study period (2018 to 2026), at a significant CAGR.
KOL Views
To keep up with the market trends, we take KOLs and SME's opinion working in Drug-Eluting Stents domain through primary research to fill the data gaps and validate our secondary research. Their opinion helps to understand and validate current and emerging therapies treatment patterns or Drug-Eluting Stents market trend. This will support the clients in making informed business decisions by identifying the overall scenario of the market and the unmet needs.
Scope of the Report
- The report covers the descriptive overview of Drug-Eluting Stents, explaining its applications, advantages, and limitations, etc.
- Additionally, an all-inclusive account of the currently available Drug-Eluting Stents is provided, which will have an impact on the future market of Drug-Eluting Stents.
- A detailed review of Drug-Eluting Stents market; historical and forecasted market size is included in the report, covering devices outreach in the 7MM.
- The report provides an edge while developing business strategies, by understanding trends shaping and driving the Drug-Eluting Stents market.
Report Highlights
- The report covers descriptive overview of the Drug-Eluting Stents, explaining its applications, working mechanism, etc.
- The report is a comprehensive account of marketed devices present in the Drug-Eluting Stents market.
- The report also reviews the detailed historical and forecasted Drug-Eluting Stents market, including assessing the outreach in 7 MM.
- The report helps in developing business strategies by understanding trends shaping and driving the Drug-Eluting Stents market.
Drug-Eluting Stents Report Key Strengths
- 6 Years Forecast
- 7MM Coverage
- Competitive Landscape
- PEST Analysis
- Market Size
Drug-Eluting Stents Report Assessment
- Marketed Product profiles
- Key Products and Key Players
- Market Drivers and Barriers
- Market Forecast
- KOL'S views
Key Questions
Market Insights:
- What was the Drug-Eluting Stents market share (%) distribution in 2018 and how it will look like in 2026?
- What will be the Drug-Eluting Stents total market size as well as market size by devices across the 7MM during the forecast period (2018-2026)?
- What are the key findings pertaining to the market across the 7MM and which country will have the largest Drug-Eluting Stents market size during the forecast period (2018-2026)?
- At what CAGR, the Drug-Eluting Stents market is expected to grow in the 7MM during the forecast period (2018-2026)?
- What will be the Drug-Eluting Stents market outlook across the 7MM during the forecast period (2018-2026)?
- What will be the Drug-Eluting Stents market growth till 2026 and what will be the resultant market size in the year 2026?
- How will the market drivers, barriers and future opportunities affect the market dynamics and a subsequent analysis of the associated trends?
Competitive Landscape:
- What are the current devices available in the Drug-Eluting Stents?
- What is the Drug-Eluting Stents available in the market, their product description, regulatory milestones, product development activities, research and development activities etc.?
- How many key players are developing Drug-Eluting Stents?
- What are the key collaborations (Industry-Industry), Mergers and acquisitions, licensing activities related to the Drug-Eluting Stents?
- What are the key designations that have been granted for the current Drug-Eluting Stents?
- What are the 7MM countries historical and forecasted market of Drug-Eluting Stents?